Vera Therapeutics
Stock Forecast, Prediction & Price Target
Vera Therapeutics Financial Estimates
Vera Therapeutics Revenue Estimates
Vera Therapeutics EBITDA Estimates
Vera Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $1.86M 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $34.11M Low: $34.11M High: $34.11M avg. 0% | Avg: $209.53M Low: $209.53M High: $209.53M avg. 514.28% | Avg: $488.76M Low: $488.76M High: $488.76M avg. 133.25% |
Net Income
% change YoY
| $-32.60M N/A | $-89.05M -173.10% | $-95.99M -7.78% | Avg: $-139.11M Low: $-141.36M High: $-87.12M avg. -44.93% | Avg: $-147.12M Low: $-131.96M High: $-76.44M avg. -5.75% | Avg: $-39.29M Low: $-39.29M High: $-39.29M avg. 73.29% | Avg: $68.86M Low: $68.86M High: $68.86M avg. 275.27% |
EBITDA
% change YoY
| $-34.40M N/A | $-90.90M -164.23% | $-102.01M -12.22% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.53 N/A | -$3.35 -118.95% | -$2.25 32.83% | Avg: -$2.44 Low: -$3.31 High: -$2.04 avg. -8.61% | Avg: -$2.45 Low: -$3.09 High: -$1.79 avg. -0.11% | Avg: -$0.92 Low: -$0.92 High: -$0.92 avg. 62.39% | Avg: $1.61 Low: $1.61 High: $1.61 avg. 275.27% |
Operating Expenses
% change YoY
| $34.40M N/A | $90.90M 164.23% | $102.01M 12.22% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Vera Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 74.46% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -141.36M, average is -139.11M and high is -87.12M.
What is Vera Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 161.88% in 2025-2028.
We have gathered data from 9 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Vera Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 82.23% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$3.31, average is -$2.44 and high is $-2.04.
What is the best performing analyst?
In the last twelve months analysts have been covering Vera Therapeutics stock. The most successful analyst is Laura Chico whose win rate is 100%. He has correctly predicted 1/1 price targets.